66
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium

, , , , , , , & show all
Pages 539-548 | Received 29 Jun 2010, Accepted 12 Nov 2010, Published online: 03 Jan 2011

References

  • Prockop DJ. Marrow stroma cells as stem cells for non-hematopoietic tissues. Science. 1997;276:71–4.
  • Pittenger MF, MacKay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
  • De Bari C, Dell'Accio F, Vandenabeele F, Veermesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003;160:909–18.
  • Akijama Y, Radtke C, Honmou O, Kocsis JD. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia. 2002;39:229–36.
  • Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, . Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005;106:756–63.
  • Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. Neurosci Res. 2000;61:364–70.
  • Barry FP. Biology and clinical applications of mesenchymal stem cells. Birth Defects Res C Embryo Today. 2003;48: 3464–74.
  • Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, . Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;31:42–8.
  • Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Developmental Committee of the European Group for Blood and Marrow Transplantation, mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host-disease: a phase II study. Lancet. 2008;371:1579–86.
  • Sbano P, Cuccia A, Mazzanti B, Urbani S, Giusti B, Lapini I, . Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model. Arch Dermatol Res. 2008;300:115–24.
  • Urbani S, Caporale R, Lombardini L, Bosi A, Saccardi R. Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells. Cytotherapy. 2006;8: 243–53.
  • Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA. 2001;98:7841–5.
  • Lee RH, Hsu SC, Munoz J, Jung JS, Lee NR, Pochampally R, Prockop DJ. A subset of human rapidly self renewing marrow stromal cells preferentially engraft in mice. Blood. 2006;107:2153–61.
  • Colter DC, Class R, Di Girolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Cell Biology. 2000;97: 3213–8.
  • Lee KA, Wooyoung S, Paik MJ, Lee SC, Shim JY, Ahn YH, . Analysis of changes in the viability and gene expression profiles of human mesenchymal stromal cells over time. Cytotherapy. 2009;11:688–97.
  • Sorensen MH, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest. 2008;68:192–203.
  • Wagner W, Ho AD. Mesenchymal stem cells preparations comparing apples and oranges. Stem Cell Rev. 2007;3: 239–48.
  • Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Krause U, . The heterogeneity of human mesenchymal stem cells preparations: evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol. 2006;34:536–48.
  • Wenisch S, Trinkaus K, Hild A, Hose D, Heiss C, Alt V, . Immunochemical, ultrastructural and electrophysiological investigations of bone-derived stem cells in the course of neuronal differentiation. Bone. 2006;38:911–21.
  • Titorencu I, Jinga VV, Constantinescu E, Gafencu AV, Ciohodaru C, Manolescu I, . Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells. Cytotherapy. 2007;9:682–96.
  • Jazayeri M, Allameh A, Soleimani M, Jazayeri SH, Piryaei A, Kazemnejad S. Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells. Cell Biol Int. 2008;32:1183–92.
  • Pasquinelli G, Tazzari P, Ricci F, Vaselli C, Buzzi M, Conte R, . Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct Pathos. 2007;31:23–8.
  • Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, . Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289–301.
  • Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267–74.
  • Mazzanti B, Aldinucci A, Biagioli T, Barilaro A, Urbani S, Dal Pozzo S, . Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment. J Neuroimmunol. 2008;199:142–50.
  • Wuchter P, Boda-Heggemann J, Straub BK, Grund C, Kuhn C, Krause U, . Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells. Cell Tissue Res. 2007;328: 499–514.
  • Franke WW, Grund C, Jackson BW, Illmensee K. Formation of cytoskeletal elements during mouse embryogenesis. IV. Ultrastructure of primary mesenchymal cells and their cell–cell interactions. Differentiation. 1983;25:121–41.
  • Li YM, Benisch TP, Zeck S, Meissner-Weigl J, Schneider D, Limbert C, . Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun. 2007;363:209–15.
  • Stolzing A, Coleman N, Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells, Rejuvenation Res. 2006;9:31–5.
  • Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24:462–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.